Cargando…
Immunohistochemistry with the anti-BRAF V600E (VE1) antibody: impact of pre-analytical conditions and concordance with DNA sequencing in colorectal and papillary thyroid carcinoma
SUMMARY: The most common of all activating BRAF mutations (T1799A) leads to a substitution of valine (V) to glutamic acid (E) at the position 600 of the amino acid sequence. The major goal of this study was to compare detection of the BRAF V600E mutation by DNA sequencing with immunohistochemistry (...
Autores principales: | Dvorak, Katerina, Aggeler, Birte, Palting, John, McKelvie, Penny, Ruszkiewicz, Andrew, Waring, Paul |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4233678/ https://www.ncbi.nlm.nih.gov/pubmed/25014730 http://dx.doi.org/10.1097/PAT.0000000000000119 |
Ejemplares similares
-
Immunohistochemistry with Anti-BRAF V600E (VE1) Mouse Monoclonal Antibody is a Sensitive Method for Detection of the BRAF V600E Mutation in Colon Cancer: Evaluation of 120 Cases with and without KRAS Mutation and Literature Review
por: Dvorak, Katerina, et al.
Publicado: (2017) -
VE1 immunohistochemistry predicts BRAF V600E mutation status and clinical outcome in colorectal cancer
por: Schafroth, Christian, et al.
Publicado: (2015) -
VE1 Immunohistochemistry Improves the Limit of Genotyping for Detecting BRAF(V600E) Mutation in Papillary Thyroid Cancer
por: Choden, Sonam, et al.
Publicado: (2020) -
Diagnosis of fetal growth restriction in perinatal deaths using brain to liver weight ratios
por: Stephens, Alexandre S., et al.
Publicado: (2015) -
Clinicopathological characterisation of small (2 cm or less) proximal and distal gastric carcinomas in a Chinese population
por: Huang, Qin, et al.
Publicado: (2015)